Upcoming Session

LECTURE 4

Curative therapies for hemoglobin disorders


Saturday, February 27th 2021

9.00 pm (IST)



Prof. Martin H.Steinburg MDProfessor, Hematology and Medical Oncology, Boston University School of Medicine

Fetal Hemoglobin in Sickle Cell Anemia: Bedside➙Bench➙Bedside and Beyond


Saturday, February 20th 20217.00 pm (IST)[Lecture Online]

Prof. Stuart Orkin, M.D

David G. Nathan Distinguished Professor of Pediatrics, Howard Hughes Medical Institute (HHMI) InvestigatorHarvard Medical School, Boston, USA

Turning on fetal hemoglobin for therapy: mechanism and translation


February 6th, 2021, 7.00 pm (India time) and 8.30 am(Boston time) [Lecture Online]

Prof. Matthew Porteus MD PhD

Professor of Paediatrics, Stanford School of Medicine, California.

Genome Editing to Cure Hemoglobinopathies



Saturday, February 13th, 2021 9.00 pm (IST) [Lecture Online]

The sessions would be online and the link to the sessions would be communicated to registered participants

Speakers & Sessions


Prof. Stuart Orkin, M.DDavid G. Nathan Distinguished Professor of Pediatrics, Howard Hughes Medical Institute (HHMI) InvestigatorHarvard Medical School, Boston, USAFebruary 6th, 2021, 7.00 pm (India time) and 8.30 am(Boston time) [Lecture Online]
Prof. Matt Porteus MD PhDProfessor of Paediatrics, Stanford School of Medicine, California.February 13th, 2021, 9.00 pm (India time) and 7.30 am (California time)
Prof. Martin H.Steinburg MDProfessor, Hematology and Medical Oncology, Boston University School of MedicineFebruary 20th, 2021, 7.00 pm (India time) and 8.30 am (Boston time)
Prof. Mark C. Walters, MDJordan Family Director, Blood and Marrow Transplantation, Professor of PediatricsUCSF Benioff Children’s Hospital, OaklandFebruary 27th, 2021, 9.00 pm (India time) and 7.30 am (California time).
Prof. David Williams , MDLeland Fikes Professor of PediatricsHarvard Medical SchoolMarch 6th, 2021, 07.00 PM (India time)
Registration is free of cost

Hemoglobinopathies 2018

The aim of the meeting was to discuss new developments in scientific and clinical advances to counter hemoglobinopathies, including the mechanisms for new therapeutic targets, curative therapies like gene therapy and genome editing approaches. The meeting also enabled close interactions between clinicians and scientists working in the area towards creating collaborative translational efforts in the area of hemoglobinopathies.

Genomics for Precision Medicine in India

Pioneering Genomics in India for over a Decade

GUaRDIAN is a collaborative research programme towards understanding the genetic basis and molecular mechanisms underlying rare genetic disorders. We use the advanced sequencing technologies, extensive bioinformatics and animal models. Our collaborators include a large number of clinicians and scientists.

know more

Working with Clinicians and Researchers to understand Rare Diseases

GUaRDIAN is a consortium of over 280 clinicians and researchers from over 60 medical and research centers making it one of the largest clinical genomics research networks in India

> know more